A new study led by researchers at UTHealth Houston investigated both gene expression and regulation at single cell levels to ...

Panelists discuss how new anti-amyloid therapies have shifted the treatment paradigm, requiring education and confidence ...

The gene variant posing the greatest genetic risk of late-onset Alzheimer's disease (AD) is called APOE-ε4. A different variant of the same gene, APOE-ε2, is thought to confer protection against AD.

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...

Alzheimer’s may advance by breaking the brain’s internal clock—and resetting it could help fight the disease. Alzheimer’s disease often interferes with a person’s normal daily patterns. Early warning ...

Scientists may have pinpointed a way to reverse Alzheimer’s disease in an animal study. The study, led by University Hospitals Cleveland Medical Center, found that restoring a central cellular energy ...

Researchers at Rutgers Robert Wood Johnson Medical School in New Brunswick are enrolling participants in the National ...

Scientists at Northwestern University used a novel compound to arrest early stages of Alzheimer’s disease in mice — setting the stage, if all goes well, for a groundbreaking treatment in which the ...

Blood-based biomarkers, such as Roche’s pTau181 test, offer a powerful tool for identifying the right patients for Alzheimer’s disease clinical trials early. This October saw a landmark development in ...

Panelists discuss how APPs can lead early Alzheimer care through proactive coordination and patient engagement.

Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with ...

Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...